Yahong Wu

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1

Expansive discovery of chemically diverse structured macrocyclic oligoamides

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Accurate de novo design of heterochiral protein–protein interactions

Dendritic cells in cancer immunology and immunotherapy

TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Macrophages in immunoregulation and therapeutics

Peptide-based materials for cancer immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Biomaterials for vaccine-based cancer immunotherapy

A timeline of tumour-associated macrophage biology

High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy

mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer

Harnessing innate immunity in cancer therapy

Trends in peptide drug discovery

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells

A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy

A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy

[Molecular mechanisms and relationship of M2-polarized macrophages with early response in multiple myeloma].

A Novel Recombinant Multi-Epitope Vaccine Could Induce Specific Cytotoxic T Lymphocyte Response In Vitro and In Vivo

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy